GET DAILY SIGNALSQuantinuum (QNT) Delivers Strong Q3 with +233% Revenue Jump
Key Takeaways
- Quantinuum reported third-quarter 2026 revenue of $9.1 million, up 233% year over year and above the consensus estimate of roughly $8.1 million.
- Adjusted (non-GAAP) loss per share came in at $0.29, narrower than the $0.37 loss analysts had expected.
- Management raised its full-year 2026 revenue outlook to $31 million–$34 million, up from a prior range of $28 million–$32 million.
- Adjusted gross margin improved to 74.6%, up 853 basis points from the year-ago quarter, as the company scales its commercial footprint.
- For more detail on the company's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages.
- Explore Trending AI Robots to discover AI-driven trading ideas and market insights.
Why These Results Matter
Quantinuum is a quantum computing company majority-owned by Honeywell that completed its initial public offering in June 2026. This marks only its second quarterly report as a public company, so the release serves as an important early check on whether technical strengths are translating into commercial revenue. The quantum computing sector has seen broad pressure in 2026 as investors grow more cautious on speculative growth names and longer timelines to profitability. In that environment, Quantinuum’s numbers matter less for immediate profits and more for signs of expanding bookings, stronger gross margins, and customer retention—all indicators of whether its commercialization path stays on track.
The Quarter in Detail
Quantinuum reported third-quarter 2026 revenue of $9.1 million, a 233% increase from $2.7 million in the prior-year period and above the roughly $8.1 million consensus. Adjusted net loss per share was $0.29, better than the $0.37 loss analysts had forecast. On a GAAP basis, net loss attributable to Quantinuum Inc. was $17.0 million, or $0.46 per Class A share. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Margin performance stood out. Adjusted gross margin reached 74.6%, up 853 basis points year over year, while GAAP gross margin turned positive at 33.3% versus negative 43.5% a year earlier. Total costs and expenses rose to $141.9 million from $55.6 million, driven largely by research and development spending of $97.5 million. Adjusted EBITDA was a loss of $80 million, wider than $45 million a year ago. Management raised its full-year 2026 revenue guidance to $31 million–$34 million from the prior $28 million–$32 million range.
Market Reaction
Quantinuum shares fell about 9% during Thursday’s regular session amid a broader technology selloff, then rose roughly 2% in extended trading after the release. The initial decline appeared tied to ongoing pressure on speculative growth and quantum names rather than disappointment with the results. Sentiment ahead of the report had been cautious: QNT shares had lost more than a third of their value since July and were down roughly 51% in 2026. By beating on both revenue and adjusted loss per share while raising full-year guidance, the company provided fundamental improvement that could help stabilize confidence, even though a clear path to profitability remains years away.
What to Watch Next
Investors should monitor whether Quantinuum can maintain commercial momentum into 2027. The company reported back-to-back world-record accuracy results on its Helios system, reaching 99.9995% logical fidelity in October, and noted platform adoption grew nearly 20% quarter over quarter to 215 organizations. On the commercial front, Quantinuum signed what it called its largest cloud agreement to date with a leading global financial institution, added a top-five pharmaceutical company for cancer-therapy materials research, and expanded distribution via a new hyperscaler agreement and an Oracle beta program. These enterprise ties could deliver more durable recurring revenue than one-off hardware deals.
Key items to track include bookings and remaining performance obligations, the path of adjusted gross margin, and the rate of cash use. Total costs and expenses stay elevated, and adjusted EBITDA losses are widening as the company invests heavily in R&D. Management targets positive free cash flow in 2030, with the Apollo fault-tolerant quantum computer planned for 2029. Until then, the stock will likely stay sensitive to commercialization milestones and broader risk appetite for speculative growth equities.
Using AI Tools in My Research
I frequently turn to Tickeron’s AI Screener when evaluating names in emerging sectors like quantum computing. It lets me quickly filter for technical patterns, fundamentals, and performance metrics across thousands of stocks and ETFs, helping surface comparable ideas without manual effort. The tool has become a regular part of my workflow for identifying potential opportunities in fast-moving industries.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
QNT's RSI Oscillator climbs out of oversold territory
The RSI Oscillator for QNT moved out of oversold territory on November 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 1 similar instances when the indicator left oversold territory. In 1 of the 1 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +5.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where QNT advanced for three days, in 9 of 9 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
QNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QNT as a result. In 4 of 4 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for QNT turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 2 similar instances when the indicator turned negative. In 2 of the 2 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for QNT entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.113) is normal, around the industry mean (-2.611). P/E Ratio (-23.887) is within average values for comparable stocks, (15.348). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.067) among similar stocks. P/S Ratio (81.967) is also within normal values, averaging (70.854).
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. QNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement